Search Within

Subhiksha Nandakumar

  1. "Cancer Research"
Formats
  1. Meeting Abstract (11)
Groups
  1. Sloan Kettering Institute Postdocs (11)
  2. Department of Medicine (10)
  3. Genitourinary Oncology Service (10)
  4. Solid Tumor Oncology Division (10)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (6)
  6. Computational Oncology Service (6)

More Groups

People
  1. Philip Kantoff (7)
  2. Goutam Chakraborty (6)
  3. Nikolaus Schultz (6)
  4. Ying Mazzu (6)
  5. Bastien Nguyen (5)
  6. Yuki Yoshikawa (5)

More People

Years
  1. 2022 (2)
  2. 2021 (3)
  3. 2020 (2)
  4. 2019 (4)
Publications
  1. Cancer Research (11)
Publishers
  1. American Association for Cancer Research (11)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ancestry inference and population-specific disparities in a real-world clinical sequencing cohort
    Meeting Abstract

    Arora, K.; Tran, T. N.; Kemel, Y. M.; Mehine, M.; Liu, Y.; Smith, S. A.; Nandakumar, S.; Ostrovnaya, I.; Reynolds, T. C.; Offit, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Comprehensive identification of lineage associated cancer genes in 122 histologies
    Meeting Abstract

    Bandlamudi, C.; Chatila, W. K.; Smith, S. A.; Nandakumar, S.; Bielski, C.; Nguyen, B.; Walch, H. S.; Kreitzer, C. K.; Arora, K. S.; Ngoc, T. T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Integration of genomic and clinical data from 25,000 patients identifies molecular determinants of metastatic potential and organotropisms
    Meeting Abstract

    Nguyen, B.; Fong, C.; DiNatale, R.; Luthra, A.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Rajanna, A.; Solit, D. B.; Berger, M. F.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Integrative analysis of clinical and genomic information identifies predictive markers of metastatic risk
    Meeting Abstract

    Fong, C. J.; Sanchez-Vega, F.; Ngyuen, B.; Luthra, A.; Nandakumar, S.; Walch, H.; Chatila, W.; Rajanna, A.; Zehir, A.; Berger, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Combination treatment of PARP and SRC inhibitors in BRCA2 mutated prostate cancer
    Meeting Abstract

    Khan, N.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Atiq, M.; Yoshikawa, Y.; Lee, G. S. M.; Kantoff, P.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Mechanisms of resistance to poly (ADP-ribose) polymerase inhibitors in prostate cancer
    Meeting Abstract

    Atiq, M.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Hypermethylation of miR193b reactivates master drivers of the poor prognosis prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Yoshikawa, Y.; Nandakumar, S.; Armenia, J.; Jehane, L.; Lee, G. S.; Chakraborty, G.; Kantoff, P.
    Cancer Research (2019)

    Fulltext@MSK | Save